We have a long history of making an impact in type 2 diabetes.
Our scientific efforts to profoundly understand type 2 diabetes persist
Diabetes is one of the fastest growing health challenges of the 21st century, with the number of adults living with diabetes having more than tripled over the past 20 years.
Advancements in research have made an impactful difference for patients, and there is still much more work to be done. We strive for scientific excellence and innovation in all stages of research, from discovery through approval and afterwards.
The impact of diabetes
Our work in diabetes
We are investigating the development of new treatment options to further improve the quality of life of diabetes patients.
Diabetes is a chronic illness and, as yet, there is still no cure for it. MSD has been actively conducting research into diabetes for years, to enable us to provide patients with new, innovative treatment options.
With an unwavering focus on innovation and substantiated science, we are working on researching, developing and providing drugs and vaccines. In 2007, our long-standing research program for diabetes enabled us to contribute to one of the most important advances in type 2 diabetes treatment: the introduction of a new class of treatment known as DPP-4 inhibitors.
Although diabetes patients have seen their quality of life improve considerably, there are still many who do not reach their target blood sugar levels. Nowadays, there is a new class of antidiabetic substances used to treat type 2 diabetes, known as SGLT-2 inhibitors. This gives patients further options for combination and supplementary therapy for treating type 2 diabetes.
Diabetes is one of the leading causes of death in the world. At MSD, we support information and education about these diseases and are committed to continuously improving treatment options for patients.
Director Business Unit Vaccines & Primary Care · MSD Switzerland
Our online platforms for patients and healthcare professionals
Anyone diagnosed with a chronic disease desires information and has questions about how best to live with the disease. That’s why we offer patients extensive knowledge about diabetes in easy-to-understand language and a variety of tips for everyday life. For healthcare professionals, we offer up-to-date scientific information and tools for daily practice in our web portal.
Online platform for patients
Type 2 diabetes affects more than 450,000 people in Switzerland. Are you one of them? Then you may be looking for information about living with the disease.
msd-gesundheit.ch is our online platform for patients. Here you will find the most important information explained in an easy-to-understand way. This includes information about the disease, symptoms and treatment options, as well as tips for everyday life. Furthermore, you will get answers to the most frequently asked questions about type 2 diabetes.
Online platform for healthcare professionals
Are you a healthcare professional looking for scientific information?
Discover mymsd.ch, our web portal exclusively for healthcare professionals. It offers information on MSD medicines, study summaries as video and PDF, current publications on the safety and efficacy of MSD medicines, access to the online store for ordering MSD products, information material for physicians and patients, and much more.